Gene · 554
Papers2,697
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,361 to 1,380 of 2,697
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Eph A10-modified pH-sensitive liposomes loaded with novel triphenylphosphine-docetaxel conjugate possess hierarchical targetability and sufficient antitumor effect both in vitro and in vivo. | Drug Deliv | 2018 | 29513049 | PubTator, text mining | PubMed |
| Clinical and genetic characteristics of 15 families with hereditary hypophosphatemia: Novel Mutations in PHEX and SLC34A3. | PLoS One | 2018 | 29505567 | PubTator, text mining | PubMed |
| A case report with shock induced by tolvaptan in an elderly patient with congestive heart failure. | Medicine (Baltimore) | 2018 | 29505505 | PubTator, text mining | PubMed |
| A Review of Oxytocin and Arginine-Vasopressin Receptors and Their Modulation of Autism Spectrum Disorder. | Front Mol Neurosci | 2018 | 29487501 | PubTator, text mining | PubMed |
| Use of acetazolamide in lithium-induced nephrogenic diabetes insipidus: a case report. | Endocrinol Diabetes Metab Case Rep | 2018 | 29479446 | PubTator, text mining | PubMed |
| Activation of AQP2 water channels without vasopressin: therapeutic strategies for congenital nephrogenic diabetes insipidus. | Clin Exp Nephrol | 2018 | 29478202 | PubTator, text mining | PubMed |
| Adult female with symptomatic AVPR2-related nephrogenic syndrome of inappropriate antidiuresis (NSIAD). | Endocrinol Diabetes Metab Case Rep | 2018 | 29472987 | PubTator, text mining | PubMed |
| Hormone treatments in congestive heart failure. | J Int Med Res | 2018 | 29468912 | PubTator, text mining | PubMed |
| Can Tolvaptan Protect Renal Function in the Early Postoperative Period of Cardiac Surgery? - Results of a Single-Center Randomized Controlled Study. | Circ J | 2018 | 29467353 | PubTator, text mining | PubMed |
| Arrestins: structural disorder creates rich functionality. | Protein Cell | 2018 | 29453740 | PubTator, text mining | PubMed |
| Is the light at the end of the tunnel nigh? A review of ADPKD focusing on the burden of disease and tolvaptan as a new treatment. | Int J Nephrol Renovasc Dis | 2018 | 29440922 | PubTator, text mining | PubMed |
| A model to predict disease progression in patients with autosomal dominant polycystic kidney disease (ADPKD): the ADPKD Outcomes Model. | BMC Nephrol | 2018 | 29439650 | PubTator, text mining | PubMed |
| Vasopressin in Heart Failure. | Endocr Metab Immune Disord Drug Targets | 2018 | 29437026 | PubTator, text mining | PubMed |
| Oxytocin structure and function in New World monkeys: from pharmacology to behavior. | Integr Zool | 2018 | 29436774 | PubTator, text mining | PubMed |
| Ménière's Disease Pathophysiology: Endolymphatic Sac Immunohistochemical Study of Aquaporin-2, V2R Vasopressin Receptor, NKCC2, and TRPV4. | Otolaryngol Head Neck Surg | 2018 | 29436285 | PubTator, text mining | PubMed |
| Tolvaptan in the treatment of autosomal dominant polycystic kidney disease: patient selection and special considerations. | Int J Nephrol Renovasc Dis | 2018 | 29430193 | PubTator, text mining | PubMed |
| Pharmacotherapy for Nocturia. | Curr Urol Rep | 2018 | 29427214 | PubTator, text mining | PubMed |
| AP2σ Mutations Impair Calcium-Sensing Receptor Trafficking and Signaling, and Show an Endosomal Pathway to Spatially Direct G-Protein Selectivity. | Cell Rep | 2018 | 29420171 | PubTator, text mining | PubMed |
| Contiguous 22.1-kb deletion embracing AVPR2 and ARHGAP4 genes at novel breakpoints leads to nephrogenic diabetes insipidus in a Chinese pedigree. | BMC Nephrol | 2018 | 29394883 | PubTator, text mining | PubMed |
| An AKAP-Lbc-RhoA interaction inhibitor promotes the translocation of aquaporin-2 to the plasma membrane of renal collecting duct principal cells. | PLoS One | 2018 | 29373579 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/554/papers?page=69